Listen to Dr. Paul Sorajja, Interventional Cardiologist at Banner University Medical Center Phoenix, describe the first implantation of the AMEND annuloplasty ring via a novel trans-septal system designed to help a leaky mitral valve. Video here: New catheter procedure treats leaky heart valves - Arizona PBS For additional news coverage: Medical breakthrough helps patients [...]
Watch DeviceTalks host Tom Salemi interview Steve Sandweg CEO and Dr. David Meerkin CMO as they discuss how Valcare’s AMEND™ TMVr Annuloplasty System is re-engineering mitral valve repair. Register here to gain immediate access to view the webinar recording. Webinar Overview Surgical Annuloplasty has long been the gold standard for restoring mitral valve function. [...]
WILMINGTON, Del., February 11, 2026 /PRNewswire/ — Valcare Medical, Inc., a pioneer developer in transcatheter mitral valve repair solutions, today announced the successful first U.S. transseptal implantation of its AMEND™ Transcatheter Mitral Valve Repair (TMVr) Annuloplasty System as part of the ongoing AMEND TS Early Feasibility Study (EFS). The milestone procedure was performed by [...]
HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND™ Trans-Septal System for investigational device exemption (IDE) application to commence an Early Feasibility Study (EFS). The AMEND™ Trans-Septal System is a trans catheter device intended for treatment [...]
TAMPA, Fla., July 25, 2024 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, announces the expansion of the AMEND™ TS EU Pilot Study to Italy. The Italian Ministry of Health has approved the extension to include multiple centers throughout Italy, building upon the initial cases conducted in Portugal earlier this [...]
TAMPA, Fla., July 2, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced the formation of a Scientific Advisory Board (SAB) comprised of distinguished experts. The SAB will provide expert insight and guidance while helping the Company further advance its research and development initiatives for the AMEND mitral valve repair [...]
TAMPA, Fla., May 14, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, announces the successful completion of the first two enrollments in the AMEND TS European pilot study. Dr. Bruno Melica and the team from Vila Nova de Gaia Hospital, Portugal, performed the procedures. The purpose of the study is to build upon [...]
TAMPA, Fla., April 24, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced a comprehensive corporate restructure by a group of investors led by Techwald Next, aimed at accelerating the company's plans to initiate the AMEND mitral annuloplasty clinical studies in Europe and the United States. As part of the restructuring, TechWald has appointed Steve [...]
Israeli heart valve device developer Valcare Medical today announced the 1st implantations of its Amend mitral valve repair annuloplasty ring, completing the 1st phase of its 1st-in-human multi-center clinical trial evaluating the device.